CVS Health

CVS Health's net profit rose 53.7% yoy to USD 2,975 mil in 2Q2020

By Helgi Analytics - August 13, 2020

CVS Health made a net profit of USD 2,975 mil with revenues of USD 65,341 mil in 2Q2020, up by 53.7% and up by 3.01%, ...

CVS Health's Total Cash From Operations rose 33.4% yoy to USD 7,119 mil in 2Q2020

By Helgi Analytics - August 13, 2020

CVS Health's operating cash flow stood at USD 7,119 mil in 2Q2020, up 33.4% when compared to the previous year. Historic...

CVS Health's Cash & Cash Equivalents rose 105% yoy to USD 17,465 mil in 2Q2020

By Helgi Analytics - August 13, 2020

CVS Health's total assets reached USD 235,495 mil at the end of 2Q2020, up 7.58% compared to the previous year. Current as...

Profit Statement 2017 2018 2019
Sales USD mil 184,786 194,579 256,776
Gross Profit USD mil 28,528 31,538 45,528
EBITDA USD mil 12,017 6,739 19,028
EBIT USD mil 9,538 4,021 11,987
Financing Cost USD mil 1,062 2,619 3,035
Pre-Tax Profit USD mil 8,268 1,406 8,997
Net Profit USD mil 6,622 -594 6,634
Dividends USD mil 2,040 2,088 2,602
Balance Sheet 2017 2018 2019
Total Assets USD mil 95,131 196,456 222,449
Non-Current Assets USD mil 63,902 151,213 172,147
Current Assets USD mil 31,229 45,243 50,302
Working Capital USD mil 19,614 19,946 19,762
Shareholders' Equity USD mil 37,695 58,543 64,170
Liabilities USD mil 57,436 137,913 158,279
Total Debt USD mil 27,002 73,429 89,002
Net Debt USD mil 25,195 66,848 80,946
Ratios 2017 2018 2019
ROE % 17.8 -1.23 10.8
ROCE % 7.98 -0.466 3.65
Gross Margin % 15.4 16.2 17.7
EBITDA Margin % 6.50 3.46 7.41
EBIT Margin % 5.16 2.07 4.67
Net Margin % 3.58 -0.305 2.58
Net Debt/EBITDA 2.10 9.92 4.25
Net Debt/Equity % 66.8 114 126
Cost of Financing % 3.89 5.22 3.74
Valuation 2017 2018 2019
Market Capitalisation USD mil 73,515 84,848 96,726
Enterprise Value (EV) USD mil 98,710 151,696 177,672
Number Of Shares mil 1,024 1,044 1,305
Share Price USD 66.6 61.9 72.6
EV/EBITDA 8.21 22.5 9.34
EV/Sales 0.534 0.780 0.692
Price/Earnings (P/E) 10.3 -109 14.3
Price/Book Value (P/BV) 1.81 1.10 1.48
Dividend Yield % 3.00 3.23 2.75

Get all company financials in excel:

Download Sample   $19.99

overview Unit 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
income statement                                                      
Sales USD mil ... ... ... ... ... ... ...                           126,761 139,367 153,290 177,546 184,786    
Gross Profit USD mil ... ... ... ... ... ... ...                           23,783 25,367 26,528 28,834 28,528    
EBIT USD mil ... ... ... ... ... ... ...                           8,037 8,799 9,475 10,386 9,538    
Net Profit USD mil ... ... ... ... ... ... ...                           4,592 4,644 5,237 5,317 6,622    
                                                         
ROE % ... ... ... ... ... ... ... ...                         12.1 12.2 13.9 14.4 17.8    
EBIT Margin % ... ... ... ... ... ... ...                           6.34 6.31 6.18 5.85 5.16    
Net Margin % ... ... ... ... ... ... ...                           3.62 3.33 3.42 2.99 3.58    
Employees ... ... ... ... ... ... ...                   ... ... ...   ... 137,800 155,000 158,000 160,000    
balance sheet                                                      
Total Assets USD mil ... ... ... ... ... ... ...                           71,526 74,187 92,437 94,462 95,131    
Non-Current Assets USD mil ... ... ... ... ... ... ...                           46,201 48,204 63,279 63,420 63,902    
Current Assets USD mil ... ... ... ... ... ... ...                           25,325 25,983 29,158 31,042 31,229    
                                                         
Shareholders' Equity USD mil ... ... ... ... ... ... ...                           37,938 37,963 37,242 36,834 37,695    
Liabilities USD mil ... ... ... ... ... ... ...                           33,588 36,224 55,195 57,628 57,436    
Non-Current Liabilities USD mil ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  
Current Liabilities USD mil ... ... ... ... ... ... ...                           15,425 19,027 23,169 26,250 30,648    
                                                         
Net Debt/EBITDA ... ... ... ... ... ... ...                           0.931 0.967 2.15 1.87 2.10    
Net Debt/Equity % ... ... ... ... ... ... ...                           24.3 27.3 66.9 65.4 66.8    
Cost of Financing % ... ... ... ... ... ... ... ...                         4.45 4.68 4.26 3.92 3.89    
cash flow                                                      
Total Cash From Operations USD mil ... ... ... ... ... ... ...                           5,783 8,137 8,539 10,141 8,007    
Total Cash From Investing USD mil ... ... ... ... ... ... ...                           -1,835 -4,045 -13,420 -2,470 -2,877    
Total Cash From Financing USD mil ... ... ... ... ... ... ...                           -1,237 -5,694 4,879 -6,761 -6,751    
Net Change In Cash USD mil ... ... ... ... ... ... ...                           2,714 -1,608 -22.0 912 -1,620    
valuation                                                      
Market Capitalisation USD mil                                         84,453 109,793 107,645 83,724 73,515    
Enterprise Value (EV) USD mil ... ... ... ... ... ... ...                           93,678 120,168 132,562 107,797 98,710    
Number Of Shares mil                                         1,226 1,169 1,126 1,079 1,024    
Share Price USD                                         61.2 83.6 86.0 70.7 66.6    
Price/Earnings (P/E)             ...                           16.4 21.1 18.6 14.4 10.3    
Price/Cash Earnings (P/CE) ... ... ... ... ... ... ... ... ...       ... ... ... ... ...   ...   12.5 16.2 14.4 10.9 8.20    
EV/EBITDA ... ... ... ... ... ... ...                           9.46 11.2 11.5 8.38 8.21    
Price/Book Value (P/BV) ... ... ... ... ... ... ...                           1.98 2.57 2.60 2.07 1.81    
Dividend Yield %                                         1.47 1.32 1.63 2.41 3.00    
income statement Unit 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
income statement                                                      
Sales USD mil ... ... ... ... ... ... ...                           126,761 139,367 153,290 177,546 184,786    
Cost of Goods & Services USD mil ... ... ... ... ... ... ...                           102,978 114,000 126,762 148,712 156,258    
Gross Profit USD mil ... ... ... ... ... ... ...                           23,783 25,367 26,528 28,834 28,528    
Selling, General & Admin USD mil ... ... ... ... ... ... ... ... ... ... ...     ... ... ... ... ... ... ... ... ... ... ... ... ... ...
Research & Development USD mil ... ... ... ... ... ... ... ... ... ... ... ... ... ...   ...         0 0 0 0 0    
Other Operating Expense USD mil ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...         15,746 16,568 17,053 18,448 18,760    
Other Operating Cost (Income) USD mil ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...         0 0 0 0 0    
EBITDA USD mil ... ... ... ... ... ... ...                           9,907 10,730 11,567 12,861 12,017    
Depreciation USD mil ... ... ... ... ... ... ... ... ...       ... ... ... ... ...   ...   1,400 1,400 1,481 1,700 1,700    
EBIT USD mil ... ... ... ... ... ... ...                           8,037 8,799 9,475 10,386 9,538    
Net Financing Cost USD mil ... ... ... ... ... ... ... ... ... ... ...                   509 600 838 1,078 1,062    
Financing Cost USD mil ... ... ... ... ... ... ...                           517 615 859 1,078 1,062    
Financing Income USD mil ... ... ... ... ... ... ...                           8.00 15.0 21.0 0 0    
FX (Gain) Loss USD mil ... ... ... ... ... ... ...   ...                       0 0 0 0 0    
Extraordinary Cost USD mil ... ... ... ... ... ... ...   ...                       8.00 1.00 -9.00 1.00 8.00    
Pre-Tax Profit USD mil ... ... ... ... ... ... ...                           7,528 7,678 8,616 8,637 8,268    
Tax USD mil ... ... ... ... ... ... ...                           2,928 3,033 3,386 3,317 1,637    
Minorities USD mil ... ... ... ... ... ... ...   ...                       0 0 2.00 2.00 1.00    
Net Profit USD mil ... ... ... ... ... ... ...                           4,592 4,644 5,237 5,317 6,622    
Net Profit Avail. to Common USD mil ... ... ... ... ... ... ...                           4,592 4,625 5,210 5,317 6,622    
Dividends USD mil ... ... ... ... ... ... ...                           1,095 1,277 1,565 1,824 2,040    
growth rates                                                      
Total Revenue Growth % ... ... ... ... ... ... ... ...                         2.96 9.94 9.99 15.8 4.08    
Operating Cost Growth % ... ... ... ... ... ... ... ...                         3.06 5.22 2.93 8.18 2.94    
EBITDA Growth % ... ... ... ... ... ... ... ...                         10.5 8.31 7.80 11.2 -6.56    
EBIT Growth % ... ... ... ... ... ... ... ...                         11.5 9.48 7.68 9.61 -8.16    
Pre-Tax Profit Growth % ... ... ... ... ... ... ... ...                         19.4 1.99 12.2 0.244 -4.27    
Net Profit Growth % ... ... ... ... ... ... ... ...                         18.8 0.719 12.6 2.05 24.5    
ratios                                                      
ROE % ... ... ... ... ... ... ... ...                         12.1 12.2 13.9 14.4 17.8    
ROA % ... ... ... ... ... ... ... ...                         6.67 6.37 6.29 5.69 6.99    
ROCE % ... ... ... ... ... ... ... ...                         7.72 7.51 7.23 6.48 7.98    
Gross Margin % ... ... ... ... ... ... ...                           18.8 18.2 17.3 16.2 15.4    
EBITDA Margin % ... ... ... ... ... ... ...                           7.82 7.70 7.55 7.24 6.50    
EBIT Margin % ... ... ... ... ... ... ...                           6.34 6.31 6.18 5.85 5.16    
Net Margin % ... ... ... ... ... ... ...                           3.62 3.33 3.42 2.99 3.58    
Payout Ratio % ... ... ... ... ... ... ...                           23.9 27.5 29.9 34.3 30.8    
Cost of Financing % ... ... ... ... ... ... ... ...                         4.45 4.68 4.26 3.92 3.89    
Net Debt/EBITDA ... ... ... ... ... ... ...                           0.931 0.967 2.15 1.87 2.10    
balance sheet Unit 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
balance sheet                                                      
Cash & Cash Equivalents USD mil ... ... ... ... ... ... ...                           4,177 2,515 2,547 3,458 1,807    
Receivables USD mil ... ... ... ... ... ... ...                           8,729 9,687 11,888 12,164 13,181    
Inventories USD mil ... ... ... ... ... ... ...                           11,045 11,930 14,001 14,760 15,296    
Other ST Assets USD mil ... ... ... ... ... ... ...                           1,374 1,851 722 660 945    
Current Assets USD mil ... ... ... ... ... ... ...                           25,325 25,983 29,158 31,042 31,229    
Property, Plant & Equipment USD mil ... ... ... ... ... ... ...                           8,615 8,843 9,855 10,175 10,292    
LT Investments & Receivables USD mil ... ... ... ... ... ... ...                           0 0 0 0 0    
Intangible Assets USD mil ... ... ... ... ... ... ...                           36,071 37,916 51,984 51,760 52,081    
Goodwill USD mil ... ... ... ... ... ... ...                           26,542 28,142 38,106 38,249 38,451    
Non-Current Assets USD mil ... ... ... ... ... ... ...                           46,201 48,204 63,279 63,420 63,902    
Total Assets USD mil ... ... ... ... ... ... ...                           71,526 74,187 92,437 94,462 95,131    
                                                         
Trade Payables USD mil ... ... ... ... ... ... ...                           5,548 6,547 7,490 7,946 8,863    
Short-Term Debt USD mil ... ... ... ... ... ... ...                           561 1,260 1,197 1,916 4,821    
Other ST Liabilities USD mil ... ... ... ... ... ... ...                           0 0 0 0 23.0    
Current Liabilities USD mil ... ... ... ... ... ... ...                           15,425 19,027 23,169 26,250 30,648    
Long-Term Debt USD mil ... ... ... ... ... ... ...                           12,841 11,630 26,267 25,615 22,181    
Other LT Liabilities USD mil ... ... ... ... ... ... ...                           5,322 5,567 5,759 5,763 4,607    
Non-Current Liabilities USD mil ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  
Liabilities USD mil ... ... ... ... ... ... ...                           33,588 36,224 55,195 57,628 57,436    
Preferred Equity and Hybrid Capital USD mil ... ... ... ... ... ... ...                           0 0 0 0 0    
Share Capital USD mil ... ... ... ... ... ... ...                           29,794 30,435 30,965 31,635 32,096    
Treasury Stock USD mil ... ... ... ... ... ... ...                           20,169 24,078 28,886 33,452 37,765    
Equity Before Minority Interest USD mil ... ... ... ... ... ... ...                           37,938 37,958 37,196 36,830 37,691    
Minority Interest USD mil ... ... ... ... ... ... ...                           0 5.00 46.0 4.00 4.00    
Equity USD mil ... ... ... ... ... ... ...                           37,938 37,963 37,242 36,834 37,695    
growth rates                                                      
Total Asset Growth % ... ... ... ... ... ... ... ...                         8.01 3.72 24.6 2.19 0.708    
Shareholders' Equity Growth % ... ... ... ... ... ... ... ...                         0.757 0.066 -1.90 -1.10 2.34    
Net Debt Growth % ... ... ... ... ... ... ... ...                         9.20 12.5 140 -3.39 4.66    
Total Debt Growth % ... ... ... ... ... ... ... ...                         36.4 -3.82 113 0.244 -1.92    
ratios                                                      
Total Debt USD mil ... ... ... ... ... ... ...                           13,402 12,890 27,464 27,531 27,002    
Net Debt USD mil ... ... ... ... ... ... ...                           9,225 10,375 24,917 24,073 25,195    
Working Capital USD mil ... ... ... ... ... ... ...                           14,226 15,070 18,399 18,978 19,614    
Capital Employed USD mil ... ... ... ... ... ... ...                           60,427 63,274 81,678 82,398 83,516    
Net Debt/Equity % ... ... ... ... ... ... ...                           24.3 27.3 66.9 65.4 66.8    
Current Ratio ... ... ... ... ... ... ...                           1.64 1.37 1.26 1.18 1.02    
Quick Ratio ... ... ... ... ... ... ...                           0.837 0.641 0.623 0.595 0.489    
cash flow Unit 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
cash flow                                                      
Net Profit USD mil ... ... ... ... ... ... ...                           4,592 4,644 5,237 5,317 6,622    
Depreciation USD mil ... ... ... ... ... ... ... ... ...       ... ... ... ... ...   ...   1,400 1,400 1,481 1,700 1,700    
Non-Cash Items USD mil ... ... ... ... ... ... ...                           -81.0 650 -136 1,164 -1,349    
Change in Working Capital USD mil ... ... ... ... ... ... ...                           -598 912 1,346 1,185 255    
Total Cash From Operations USD mil ... ... ... ... ... ... ...                           5,783 8,137 8,539 10,141 8,007    
                                                         
Capital Expenditures USD mil ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...         -1,930 -2,125 -2,332 -2,224 -1,918    
Net Change in LT Investment USD mil ... ... ... ... ... ... ...                           600 515 411 230 265    
Net Cash From Acquisitions USD mil ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...         -415 -2,439 -11,475 -524 -1,181    
Other Investing Activities USD mil ... ... ... ... ... ... ...                           -90.0 4.00 -24.0 48.0 -43.0    
Total Cash From Investing USD mil ... ... ... ... ... ... ...                           -1,835 -4,045 -13,420 -2,470 -2,877    
                                                         
Dividends Paid USD mil ... ... ... ... ... ... ...                           -1,097 -1,288 -1,576 -1,840 -2,049    
Issuance Of Shares USD mil ... ... ... ... ... ... ...                           -3,414 -3,474 -4,639 -4,165 -4,032    
Issuance Of Debt USD mil ... ... ... ... ... ... ...                           3,274 -932 11,218 -614 -598    
Other Financing Activities USD mil ... ... ... ... ... ... ...                           0 0 -124 -142 -72.0    
Total Cash From Financing USD mil ... ... ... ... ... ... ...                           -1,237 -5,694 4,879 -6,761 -6,751    
                                                         
Effect of FX Rates USD mil ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...         3.00 -6.00 -20.0 2.00 1.00    
Net Change In Cash USD mil ... ... ... ... ... ... ...                           2,714 -1,608 -22.0 912 -1,620    
ratios                                                      
Days Sales Outstanding days ... ... ... ... ... ... ...                           25.1 25.4 28.3 25.0 26.0    
Days Sales Of Inventory days ... ... ... ... ... ... ...                           39.1 38.2 40.3 36.2 35.7    
Days Payable Outstanding days ... ... ... ... ... ... ...                           19.7 21.0 21.6 19.5 20.7    
Cash Conversion Cycle days ... ... ... ... ... ... ...                           44.6 42.6 47.1 41.7 41.1    
Cash Earnings USD mil ... ... ... ... ... ... ... ... ...       ... ... ... ... ...   ...   5,992 6,044 6,718 7,017 8,322    
Free Cash Flow USD mil ... ... ... ... ... ... ...                           3,948 4,092 -4,881 7,671 5,130    
Capital Expenditures (As % of Sales) % ... ... ... ... ... ... ...                           1.52 1.52 1.52 1.25 1.04    
other ratios Unit 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
                                                       
Employees ... ... ... ... ... ... ...                   ... ... ...   ... 137,800 155,000 158,000 160,000    
Women (As % of Workforce) % ... ... ... ... ... ... ... ... ... ... ... ... ... ...             67.0 67.0 68.0 68.0 68.0    
Women (As % of Management) % ... ... ... ... ... ... ... ... ... ... ... ... ... ...             ... ... ... ... ...    
Operating Cost (As % of Sales) % ... ... ... ... ... ... ...                           12.4 11.9 11.1 10.4 10.3    
Research & Development (As % of Sales) % ... ... ... ... ... ... ... ... ... ... ... ... ... ...   ...         0 0 0 0 0    
Effective Tax Rate % ... ... ... ... ... ... ...                           38.9 39.5 39.3 38.4 19.8    
Total Revenue Growth (5-year average) % ... ... ... ... ... ... ... ... ... ... ... ...                 7.70 7.25 9.86 10.6 8.46    
Total Revenue Growth (10-year average) % ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...       16.9 16.4 15.3 15.0 9.24    
valuation Unit 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
                                                       
Market Capitalisation USD mil                                         84,453 109,793 107,645 83,724 73,515    
Enterprise Value (EV) USD mil ... ... ... ... ... ... ...                           93,678 120,168 132,562 107,797 98,710    
Number Of Shares mil                                         1,226 1,169 1,126 1,079 1,024    
Share Price USD                                         61.2 83.6 86.0 70.7 66.6    
EV/EBITDA ... ... ... ... ... ... ...                           9.46 11.2 11.5 8.38 8.21    
Price/Earnings (P/E)             ...                           16.4 21.1 18.6 14.4 10.3    
Price/Cash Earnings (P/CE) ... ... ... ... ... ... ... ... ...       ... ... ... ... ...   ...   12.5 16.2 14.4 10.9 8.20    
P/FCF ... ... ... ... ... ... ...                           19.0 23.9 -19.8 9.94 13.3    
Price/Book Value (P/BV) ... ... ... ... ... ... ...                           1.98 2.57 2.60 2.07 1.81    
Dividend Yield %                                         1.47 1.32 1.63 2.41 3.00    
Free Cash Flow Yield % ... ... ... ... ... ... ...                           4.67 3.73 -4.53 9.16 6.98    
Earnings Per Share (EPS) USD             ...                           3.74 3.96 4.63 4.90 6.44    
Cash Earnings Per Share USD ... ... ... ... ... ... ... ... ...       ... ... ... ... ...   ...   4.89 5.17 5.97 6.50 8.13    
Free Cash Flow Per Share USD ... ... ... ... ... ... ...                           3.22 3.50 -4.33 7.11 5.01    
Book Value Per Share USD ... ... ... ... ... ... ...                           30.9 32.5 33.1 34.1 36.8    
Dividend Per Share USD                                         0.900 1.10 1.40 1.70 2.00    
EV/Sales ... ... ... ... ... ... ...                           0.739 0.862 0.865 0.607 0.534    
EV/EBIT ... ... ... ... ... ... ...                           11.7 13.7 14.0 10.4 10.3    
EV/Free Cash Flow ... ... ... ... ... ... ...                           23.7 29.4 -27.2 14.1 19.2    
EV/Capital Employed ... ... ... ... ... ... ...                           1.55 1.90 1.62 1.31 1.18    
Earnings Per Share Growth % ...           ... ...                         23.8 5.88 16.9 5.83 31.4    
Cash Earnings Per Share Growth % ... ... ... ... ... ... ... ... ... ...     ... ... ... ... ... ... ... ... 21.1 5.79 15.4 9.00 25.0    
Book Value Per Share Growth % ... ... ... ... ... ... ... ...                         5.19 4.95 1.85 3.21 7.83    

Get all company financials in excel:

Download Sample   $19.99

CVS Health's net profit rose 1,217% yoy to USD 6,634 mil in 2019

By Helgi Analytics - August 13, 2020

CVS Health made a net profit of USD 6,634 mil in 2019, up 1% compared to the previous year. Total sales reached USD 256,776 mil, which is up 32% when compared to the previous year. Historically, between 2000 and 2019, the company’s net profit reach...

CVS Health's price/earnings (P/E) rose 113% yoy to 14.3 in 2019

By Helgi Analytics - August 13, 2020

CVS Health stock traded at USD 72.6 per share at the end 2019 translating into a market capitalization of USD 96,726 mil. Since the end of 2014, stock has depreciated by 13.1% representing an annual average growth of -2.78%. In absolute terms, the value...

CVS Health's Share Price rose 17.3% yoy to USD 72.6 in 2019

By Helgi Analytics - August 13, 2020

CVS Health stock traded at USD 72.6 per share at the end 2019 implying a market capitalization of USD 96,726 mil. Since the end of 2014, stock has appreciated by -13.1% implying an annual average growth of -2.78% In absolute terms, the value of the company ...

CVS Health's Capital Expenditures fell 20.6% yoy to USD 2,457 mil in 2019

By Helgi Analytics - August 13, 2020

CVS Health invested a total of USD 2,457 mil in 2019, up 20.6% compared to the previous year. Historically, between 2009 - 2019, the company's investments stood at a high of USD 2,525 mil in 2009 and a low of USD 1,868 mil in 2011. As...

CVS Health's ROCE rose 883% yoy to 3.65% in 2019

By Helgi Analytics - August 13, 2020

CVS Health made a net profit of USD 6,634 mil in 2019, up 1% compared to the previous year. Historically, between 2000 and 2019, the company's net profit reached a high of USD 6,634 mil in 2019 and a low of USD -594 mil in 2018. The result implies a retur...

CVS Health's Net Debt/EBITDA fell 57.1% yoy to 4.25 in 2019

By Helgi Analytics - August 13, 2020

CVS Health's net debt stood at USD 80,946 mil and accounted for 126% of equity at the end of 2019. The ratio is up 12.0 pp compared to the previous year. Historically, the firm’s net debt to equity reached a high of 126% in 2019 and a low of ...

CVS Health's P/FCF rose 631% yoy to 9.97 in 2019

By Helgi Analytics - August 13, 2020

CVS Health stock traded at USD 72.6 per share at the end 2019 translating into a market capitalization of USD 96,726 mil. Since the end of 2014, the stock has depreciated by 13.1% representing an annual average growth of -2.78%. At the end of 2019, the f...

CVS Health's Net Margin rose 946% yoy to 2.58% in 2019

By Helgi Analytics - August 13, 2020

CVS Health made a net profit of USD 6,634 mil with revenues of USD 256,776 mil in 2019, up by 1.00% and up by 32.0%, respectively, compared to the previous year. This translates into a net margin of 2.58%. Historically, between 2000 and 2019, the fi...

More News

CVS Health Corporation is an integrated pharmacy health care provider. The Company's offerings include pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. The Company operates drugstores throughout the U.S., the District of Columbia, and Puerto Rico. Company’s retail segment sells prescription and over-the-counter drugs, beauty and personal care products, and cosmetics; and provides health care services through its MinuteClinic walk-in medical clinics. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to chronic care facilities and other care settings. At the end of 2019, it operated approximately 9,900 retail locations and 1,100 MinuteClinic locations, as well as online retail pharmacy websites, LTC pharmacies, and onsite pharmacies

CVS Health Logo

Finance

CVS Health has been growing its sales by 13.0% a year on average in the last 5 years. EBITDA has grown on average by 12.1% a year during that time to total of USD 19,028 mil in 2019, or 7.41% of sales. That’s compared to 6.43% average margin seen in last five years.

The company netted USD 6,634 mil in 2019 implying ROE of 10.8% and ROCE of 3.65%. Again, the average figures were 11.1% and 4.98%, respectively when looking at the previous 5 years.

CVS Health’s net debt amounted to USD 80,946 mil at the end of 2019, or 126% of equity. When compared to EBITDA, net debt was 4.25x, up when compared to average of 4.06x seen in the last 5 years.

Valuation

CVS Health stock traded at USD 72.6 per share at the end of 2019 resulting in a market capitalization of USD 96,726 mil. Over the previous five years, stock price fell by 13.1% or -2.78% a year on average. The closing price put stock at a 12-month trailing EV/EBITDA of 9.34x and price to earnings (PE) of 14.3x as of 2019.

More Companies in American Retail & Wholesale Sector